Search Results
197 items found for "POTS"
- 📰 GPCR Weekly News, January 30 to February 5, 2023
Multiple Potassium Channel Tetramerization Domain (KCTD) family members interact with Gβγ, with effects Progressive Technologies and Approaches Revealing Novel GPCR Biology and Drug Development Potential.
- 📰 GPCR Weekly News, January 23 to 29, 2023
Progressive Technologies and Approaches Revealing Novel GPCR Biology and Drug Development Potential.
- 📰 GPCR Weekly News, January 16 to 22, 2023
Progressive Technologies and Approaches Revealing Novel GPCR Biology and Drug Development Potential.
- 📰 GPCR Weekly News - January 9 to 15, 2023
Progressive Technologies and Approaches Revealing Novel GPCR Biology and Drug Development Potential.
- Odorant receptors – a bit of smell for drug discovery
In the cardiovascular system, ORs have the potential to operate as the main carriers of endogenously Due to the diversity of the OR family it will be critical to select potential targets to modulate in Odorants, the natural ligands, could potentially be used as ligands and particular forms of odorant delivery
- 📰 GPCR Weekly News - January 2 to 8, 2023
Progressive Technologies and Approaches Revealing Novel GPCR Biology and Drug Development Potential.
- 📰 GPCR Weekly News
Receptor Type A Binding Affinity, Developability, and Serum Persistence Exhibits Excellent Antitumor Potency Therapeutic potential of allosteric modulators for the treatment of gastrointestinal motility disorders Identification of a potential structure-based GPCR drug for interstitial cystitis/bladder pain syndrome Progressive Technologies and Approaches Revealing Novel GPCR Biology and Drug Development Potential.
- 📰 GPCR Weekly News
Progressive Technologies and Approaches Revealing Novel GPCR Biology and Drug Development Potential.
- 📰 GPCR Weekly News
Progressive Technologies and Approaches Revealing Novel GPCR Biology and Drug Development Potential.
- 📰 GPCR Weekly News
associated peptide; TCAP) possesses independent intracellular calcium regulating actions, in vitro: A potential Progressive Technologies and Approaches Revealing Novel GPCR Biology and Drug Development Potential.
- Transmembrane domains of GPCR dimers – a novel hot spot for drug discovery
therefore preserve their physiological functions, an important observation when considering them as potential What is the potential of targeting GPCR dimer interface in drug discovery?
- Therapeutic validation of an orphan G protein‐coupled receptor
widely accepted that medium‐chain fatty acids (MCFAs) can bind to and activate this receptor with modest potency GPR84 has been additionally proposed to be a potential biomarker in different inflammatory diseases ( the function of this receptor towards clinical validation, as well as radiopharmaceuticals, including potential From these series of compounds, GLPG1205 progressed into clinical development for the potential treatment investment in better tools to study its function in both disease and physiological settings will likely potentiate
- TM5-TM6: structural switches that modulate the coupling of serotonin receptors to Gs or Gi
progress in understanding how serotonin receptors, one of the largest subfamilies of class A GPCRs and potential
- Coincident Regulation of PLCβ Signaling by Gq-Coupled and μOpioid Receptors Opposes Opioid- Mediated
Deletion of phospholipase Cβ3 (PLCβ3), or selective inhibition of Gβγ regulation of PLCβ3, enhances the potency Here we investigated a potential mechanism for regulation of PLC signaling downstream of MOR in HEK293 inhibition of its upstream regulators, Gβγ or Gq, ex vivo in periaqueductal gray (PAG) slices increased the potency Gβγ-dependent signaling cooperatively regulate PLC activation to decrease MOR-dependent antinociceptive potency
- Conservation of Allosteric Ligand Binding Sites in G-Protein Coupled Receptors
ligands there exist many other GPCRs that have a strong binding hot spot at the same location, suggesting potential allosteric modulation and help to identify the most likely binding sites among the limited number of potential
- Activation of the human chemokine receptor CX3CR1 regulated by cholesterol
chemokine receptor subfamily, CX3CR1 binds to its sole endogenous ligand CX3CL1, which shows notable potential
- Pharmacological targeting of cGAS/STING-YAP axis suppresses pathological angiogenesis and...
Further, pharmacological targeting of cGAS/STING-YAP axis exhibits the potential to alleviate liver and
- Protein Uncoupling as an Innovative Practice in Diabetes Mellitus Treatment: A Metabolic Disorder
are hypothesised to be triggered by superoxide and then reduce mitochondrial free radical production, potentially
- G protein-biased GPR3 signaling ameliorates amyloid pathology in a preclinical Alzheimer's disease..
phenotypes, including elevated anxiety-like behavior, reduced fertility, and memory impairment, which are potentially
- Label-free LC-MS based assay to characterize small molecule compound binding to cells
binding analysis by titration of five known ligands suggested a good correlation with their inhibition potency
- Developing the Cannabinoid Receptor 2 (CB2) pharmacopoeia: past, present, and future
CB2) is a G protein-coupled receptor (GPCR) with considerable, though as yet unrealised, therapeutic potential
- Pepducin-mediated G Protein-Coupled Receptor Signaling in the Cardiovascular System
to manipulate GPCR activity in an orthosteric site-independent manner to compounds with therapeutic potential each receptor, as well as the structural, signaling, pathophysiologic consequences, and therapeutic potential
- N-terminal alterations turn the gut hormone GLP-2 into an antagonist with gradual loss of GLP-2 ...
Background and purpose: To fully elucidate the regulatory role of the GLP-2 system in the gut and the bones, potent
- Glucagon receptor-mediated regulation of gluconeogenic gene transcription is endocytosis-dependent..
We further show that endocytosis potentiates cytoplasmic cAMP elevation produced by GCGR activation and
- Differences across sexes on head-twitch behavior and 5-HT2A receptor signaling in C57BL/6J mice
amphetamine 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI), is receiving renewed attention for their potential Current studies focused on the potentially clinical effects of psychedelics on human subjects tend to tested the effects of DOI on head-twitch behavior (HTR) - a mouse behavioral proxy of human psychedelic potential
- Comparative study of neuropeptide signaling systems in Hemiptera
Their expression profiles at the probe and feeding stages reflected potential regulatory roles in probe
- PH-Binding Motif in PAR4 Oncogene: From Molecular Mechanism to Drug Design
PAR4 emerges as a potent oncogene, capable of inducing tumor generation.
- Use of CRISPR/Cas9-edited HEK293 cells reveals that both conventional and novel protein kinase C...
Moreover, since pharmacological tools to study PKC isozymes generally lack specificity and/or potency